TICKDELTA
Sign in
Screener / SEC EDGAR /CIK 0000021665 /10-K filed Feb 23, 2026, compared with Feb 13, 2025 /Numbers from the XBRL of the 10-Ks
Consumer staples peers:
KDPKHCDLTRMOCLCASY
NYSE Consumer staples · Cosmetics

Colgate-Palmolive CL

CL quote by TradingView

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate-Palmolive”) is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet. 10-K, Item 1

Employees
33,600
Headquarters
New York, NY
CEO
Noel R. Wallace
Next results
around Jan 29, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $20.4B through the costs to a net profit of $2.1B · income statement of the 10-K

16% operating margin
Revenue to Gross profit: $12.3BRevenue to Cost of revenue: $8.1BGross profit to Operating profit: $3.3BGross profit to Operating expenses: $8.9BOperating profit to Net profit: $2.1BOperating profit to Tax & other: $1.2BOperating expenses to R&D: $366.0MOperating expenses to Sales, admin & other: $8.6B Revenue: $20.4B REVENUE $20.4B +1% Y/Y Gross profit: $12.3B · 60% margin GROSS PROFIT $12.3B 60% margin · +1% Y/Y Cost of revenue: $8.1B · 40% of revenue COST OF REVENUE $8.1B 40% of revenue Operating profit: $3.3B · 16% margin OPERATING PROFIT $3.3B 16% margin · −23% Y/Y Operating expenses: $8.9B · 44% of revenue OPERATING EXPENSES $8.9B 44% of revenue Net profit: $2.1B · 10% margin NET PROFIT $2.1B 10% margin · −26% Y/Y Tax & other: $1.2B · 6% of revenue TAX & OTHER $1.2B 6% of revenue R&D: $366.0M · 2% of revenue R&D $366.0M 2% of revenue Sales, admin & other: $8.6B · 42% of revenue SALES, ADMIN & OTHER $8.6B 42% of revenue
Gross profit $12.3B 60% margin · +1% Y/Y
Operating profit $3.3B 16% margin · −23% Y/Y
Net profit $2.1B 10% margin · −26% Y/Y
The full income statement, year by year

CL among Consumer staples peers

Six ratios from the latest 10-K. Each corner is the share of 32 peers the company is above, not a score.

Compare
Revenue growth: 1.4%, above 34% of 32 peers (their median 2.2%) REVENUE GROWTH 1.4% · above 34% Gross margin: 60.6%, above 83% of 30 peers (their median 38.9%) GROSS MARGIN 60.6% · above 83% Operating margin: 14.9%, above 57% of 28 peers (their median 13.6%) OPERATING MARGIN 14.9% · above 57% Net margin: 9.6%, above 53% of 32 peers (their median 7.6%) NET MARGIN 9.6% · above 53% FCF margin: 17.8%, above 81% of 32 peers (their median 10.4%) FCF MARGIN 17.8% · above 81% Return on capital: 32.7%, above 100% of 24 peers (their median 12.1%) RETURN ON CAPITAL 32.7% · above 100%
CL Peer median Below the median

What changed

5 new risk paragraphs and 1 accounting fact worth reading about. 10-K filed Feb 23, 2026 against Feb 13, 2025.

Risk factors
5 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Critical audit matters changed
New this year: Annual and Interim Goodwill Impairment Tests - Skin Health Reporting Unit (“As described in Notes 2 and 5 to the consolidated financial statements, the Company’s consolidated goodwill balance was $3,122 million as of December 31, 2025, and the goodwill associated with the skin health reporting unit was $51 million. Goodwill is subject to impairment tests at least annually o”)
10-K · XBRL
Accounting checks
10 other checks clear, 1 worth a look
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
2 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

1fact worth reading about the other 10 checks found nothing to note

  • Critical audit matters changed
    New this year: Annual and Interim Goodwill Impairment Tests - Skin Health Reporting Unit (“As described in Notes 2 and 5 to the consolidated financial statements, the Company’s consolidated goodwill balance was $3,122 million as of December 31, 2025, and the goodwill associated with the skin health reporting unit was $51 million. Goodwill is subject to impairment tests at least annually o”)
  • Receivables +10.1% vs revenue +1.4% (+8.7 pts)
9 more checks with nothing to note
  • Cash from operations $4.2B vs net income $2.1B (FY ending Dec 31, 2025)
  • Inventory +2.3% vs revenue +1.4% (+0.9 pts)
  • Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

5 paragraphs in Risk Factors that were not in the 10-K filed Feb 13, 2025. Quoted as filed.

All 5 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 13, 2025 10-K, ITEM 1A
    Negative publicity, posts or comments on digital and social media (including those that are AI-generated), whether true or untrue, could damage our brands and our reputation. The success of our brands could also suffer if our marketing initiatives do not have the desired impact on a brand’s image or its ability to attract consumers.
  2. Item 1A · new paragraph · not in the 10-K filed Feb 13, 2025 10-K, ITEM 1A
    Raw and packaging material commodities, such as resins, essential oils, tropical oils, pulp, tallow, corn, poultry and
  3. Item 1A · new paragraph · not in the 10-K filed Feb 13, 2025 10-K, ITEM 1A
    We may not realize the benefits that we expect from our Strategic Growth and Productivity Program.
  4. Item 1A · new paragraph · not in the 10-K filed Feb 13, 2025 10-K, ITEM 1A
    Our business is subject to legal and regulatory risks in the United States and abroad.

New risk paragraphs, against peers

Latest 10-K of each, Consumer staples companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$18.0B$19.5B$20.1B$20.4B
Net income$1.8B$2.3B$2.9B$2.1B
Operating cash flow$2.6B$3.7B$4.1B$4.2B
Free cash flow$1.9B$3.0B$3.5B$3.6B

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$20.4B ▲ 1.4% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

2 filings in the last 30 days · SEC EDGAR

All filings

About the company

Colgate-Palmolive, New York, NY · from the 10-K filed Feb 23, 2026

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate-Palmolive”) is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet. To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet.

Headquarters
New York, NY
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
December 31
Last results
Oct 30, 2026
Incorporated in
DE

Employees, at the top of the page: "As of December 31, 2025, we had approximately 33,600 employees based in over 100 countries" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 23, 2026 (open at SEC), compared with the 10-K filed Feb 13, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CL/export.csv") into a cell.